Back to Search
SARAH WOODMAN, M.D
M.D
Obstetrics & Gynecology Physician
NPI: 1295175297IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
MT205278(PA)
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MD461550(PA)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
OTHER
Class of 2013
Research & Publications (19)
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
PMID 19671763·Mol Cancer Ther·2009
8-other
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
PMID 14981167·Neurology·2004
4-observational
Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.
PMID 12759260·Am J Pathol·2003
7-preclinical
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
PMID 12138167·J Biol Chem·2002
7-preclinical
Mutational analysis identifies a short atypical membrane attachment sequence (KYWFYR) within caveolin-1.
PMID 11888297·Biochemistry·2002
7-preclinical
Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
PMID 18936790·Nat Clin Pract Oncol·2008
5-case
MR imaging of caveolin gene-specific alterations in right ventricular wall thickness.
PMID 15733789·Magn Reson Imaging·2005
7-preclinical
Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
PMID 14633633·Am J Pathol·2003
7-preclinical
Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.
PMID 14507673·Am J Pathol·2003
7-preclinical
Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
PMID 12839838·Am J Physiol Cell Physiol·2003
4-observational
Caveolin, caveolae, and endothelial cell function.
PMID 12689915·Arterioscler Thromb Vasc Biol·2003
6-review
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.
PMID 12388077·Am J Physiol Cell Physiol·2003
7-preclinical
Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.
PMID 12167625·J Biol Chem·2002
7-preclinical
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
PMID 12057923·Am J Pathol·2002
7-preclinical
Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14).
PMID 11451957·J Biol Chem·2001
7-preclinical
Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation.
PMID 10751368·Am J Pathol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5501 OLD YORK RD, LIFTER FIRST FLOOR,ROOM1615
PHILADELPHIA, PA 19141 - Phone
- (215) 456-8261
Quick Facts
- NPI
- 1295175297
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 13
- Publications
- 19
Are you this provider?
Claim Your Profile